Pharmaceuticals, Biotechnology and Life Sciences
TORONTO, April 18, 2022 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a…
WINSTON-SALEM, N.C., April 18, 2022 (GLOBE NEWSWIRE) — ProKidney LP (ProKidney) is a leading Phase 3 clinical-stage cellular therapeutics company…
Split Expected to be Effective for Trading Purposes as of Market Open on April 19, 2022CHARLOTTESVILLE, Va., April 18, 2022…
SOUTH SAN FRANCISCO, Calif., April 18, 2022 (GLOBE NEWSWIRE) — Senti Biosciences, Inc. (“Senti Bio”), a leading Gene Circuit company…
Castellum, Inc. Closes on the Acquisition of Lexington Solutions Group Castellum, Inc. (OTC: ONOV) announces the closing of its acquisition…
500,000+ square foot facility to support commercial-scale biomanufacturing Livestreaming ceremony with Governor Laura Kelly Live from Manhattan, Kansas today at 11:00am…
PALM BEACH GARDENS, Fla. and SUMMIT, N.J., April 15, 2022 (GLOBE NEWSWIRE) — Integrity Implants Inc. d/b/a Accelus (“Accelus”), a…
Company voluntarily withdraws UKONIQ® from sale for approved indications of relapsed/refractory MZL and FL Company to host conference call, Monday,…
Immunicum AB (“Immunicum” publ; IMMU.ST), a biopharmaceutical company focused on therapies addressing tumor recurrence and hard-to-treat established tumors, today announced…
PASADENA, CA, April 14, 2022 (GLOBE NEWSWIRE) — LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT), a clinical-stage drug discovery company developing…